Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 27
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
A Phase I/II Study of the Photon Radiosurgery System
Phase II, Phase I
CNS 0201
NCT00179907
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Phase II, Phase I
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
Antineoplaston Therapy in Treating Patients With Brain Tumors
Phase II
BC-BT-9
NCT00003457
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Phase II
BC-BT-21
NCT00003475
Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADELĀ® Wafer in Patients With Metastatic Brain Cancer
Phase II
GLIA-001
NCT00525590
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
Phase II
3368
NCT00576537
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
Phase II
12555
NCT00589706
Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
Phase II
00003596
NCT00611325
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Phase II
00000379
NCT00612430
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
Phase II
7262-07-7R2
NCT00615927
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute